{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:31:58Z","timestamp":1772166718967,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01078-9","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:03:39Z","timestamp":1769270619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preservative-free latanoprost induces meibomian gland dysfunction through inflammatory and oxidative stress pathways"],"prefix":"10.1186","volume":"27","author":[{"given":"Caihong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaolin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruochen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"1078_CR1","doi-asserted-by":"publisher","unstructured":"Nelson JD, Shimazaki J, Benitez-Del-Castillo JM, Craig JP, McCulley JP, Den S, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011, 1930-1937;52. https:\/\/doi.org\/10.1167\/iovs.10-6997b.","DOI":"10.1167\/iovs.10-6997b"},{"key":"1078_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/ico.0000000000001489","volume":"37","author":"JH Kim","year":"2018","unstructured":"Kim JH, Shin YU, Seong M, Cho HY, Kang MH. Eyelid changes related to meibomian gland dysfunction in early middle-aged patients using topical glaucoma medications. Cornea. 2018;37:421\u201325. https:\/\/doi.org\/10.1097\/ico.0000000000001489.","journal-title":"Cornea"},{"key":"1078_CR3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/ijg.0000000000000495","volume":"25","author":"MC Mocan","year":"2016","unstructured":"Mocan MC, Uzunosmanoglu E, Kocabeyoglu S, Karakaya J, Irkec M. The association of chronic topical prostaglandin analog use with meibomian gland dysfunction. J Glaucoma. 2016;25:770\u201374. https:\/\/doi.org\/10.1097\/ijg.0000000000000495.","journal-title":"J Glaucoma"},{"key":"1078_CR4","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/opx.0000000000001782","volume":"98","author":"D Soriano","year":"2021","unstructured":"Soriano D, Ferrandez B, Mateo A, Polo V, Garcia-Martin E. Meibomian gland changes in open-angle glaucoma users treated with topical Medication. Optom Vis Sci. 2021;98:1177\u201382. https:\/\/doi.org\/10.1097\/opx.0000000000001782.","journal-title":"Optom Vis Sci"},{"key":"1078_CR5","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/ico.0000000000000838","volume":"35","author":"E Uzunosmanoglu","year":"2016","unstructured":"Uzunosmanoglu E, Mocan MC, Kocabeyoglu S, Karakaya J, Irkec M. Meibomian gland dysfunction in patients receiving long-term glaucoma medications. Cornea. 2016;35:1112\u201316. https:\/\/doi.org\/10.1097\/ico.0000000000000838.","journal-title":"Cornea"},{"key":"1078_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/ijg.0000000000000841","volume":"27","author":"WH Cho","year":"2018","unstructured":"Cho WH, Lai IC, Fang PC, Chien CC, Tseng SL, Lai YH, et al. Meibomian gland performance in glaucomatous patients with long-term instillation of IOP-lowering medications. J Glaucoma. 2018;27:176\u201383. https:\/\/doi.org\/10.1097\/ijg.0000000000000841.","journal-title":"J Glaucoma"},{"key":"1078_CR7","doi-asserted-by":"publisher","first-page":"e0191398","DOI":"10.1371\/journal.pone.0191398","volume":"13","author":"TH Lee","year":"2018","unstructured":"Lee TH, Sung MS, Heo H, Park SW. Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma. PLoS One. 2018;13:e0191398. https:\/\/doi.org\/10.1371\/journal.pone.0191398.","journal-title":"PLoS One"},{"key":"1078_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/IJG.0000000000000841","volume":"27","author":"W-H Cho","year":"2018","unstructured":"Cho W-H, Lai C, Fang P-C, Chien C-C, Tseng S-L, Lai Y-H, et al. Meibomian gland performance in glaucomatous patients with long-term instillation of IOP-lowering medications. J Glaucoma. 2018;27:176\u201383.","journal-title":"J Glaucoma"},{"key":"1078_CR9","doi-asserted-by":"crossref","unstructured":"Alm A. Latanoprost in the treatment of glaucoma. Clin Ophthalmol. 2014;1967\u201385.","DOI":"10.2147\/OPTH.S59162"},{"key":"1078_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00417-012-1943-6","volume":"250","author":"R Arita","year":"2012","unstructured":"Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, et al. Effects of long-term topical anti-glaucoma medications on meibomian glands. Graefe\u2019s Archiv For Clin Exp Ophthalmol. 2012;250:1181\u201385.","journal-title":"Graefe\u2019s Archiv For Clin And Exp Ophthalmol"},{"key":"1078_CR11","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1097\/ICO.0b013e31823f8e7d","volume":"31","author":"R Arita","year":"2012","unstructured":"Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, et al. Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands. Cornea. 2012;31:1229\u201334.","journal-title":"Cornea"},{"key":"1078_CR12","doi-asserted-by":"publisher","first-page":"204209862312242","DOI":"10.1177\/20420986231224227","volume":"15","author":"T Jiang","year":"2024","unstructured":"Jiang T, Su H, Xu J, Li C, Zhang N, Li Y, et al. Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA adverse event reporting System from 2004 to 2021. Ther Adv Drug Saf. 2024;15:20420986231224227.","journal-title":"Ther Adv Drug Saf"},{"key":"1078_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cpt.3139","volume":"115","author":"D Li","year":"2024","unstructured":"Li D, Wang H, Qin C, Du D, Wang Y, Du Q, et al. Drug-induced acute pancreatitis: a real-world pharmacovigilance study using the FDA adverse event reporting System database. Clin Pharmacol Ther. 2024;115:535\u201344.","journal-title":"Clin Pharmacol Ther"},{"key":"1078_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1517\/14656566.2012.662219","volume":"13","author":"M Digiuni","year":"2012","unstructured":"Digiuni M, Fogagnolo P, Rossetti L. A review of the use of latanoprost for glaucoma since its launch. Expert Opin on Pharmacother. 2012;13:723\u201345.","journal-title":"Expert Opin On Pharmacother"},{"key":"1078_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2165\/00002512-200320080-00005","volume":"20","author":"CM Perry","year":"2003","unstructured":"Perry CM, McGavin JK, Culy CR, Ibbotson T. Latanoprost: an update of its use in glaucoma and ocular hypertension. Drugs Aging. 2003;20:597\u2013630.","journal-title":"Drugs Aging"},{"key":"1078_CR16","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1167\/iovs.18-24013","volume":"59","author":"Y Yang","year":"2018","unstructured":"Yang Y, Huang C, Lin X, Wu Y, Ouyang W, Tang L, et al. 0.005% preservative-free latanoprost induces dry eye-like ocular surface damage via promotion of inflammation in mice. Invest Ophthalmol Visual Sci. 2018;59:3375\u201384.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"1078_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/10807680260218489","volume":"18","author":"N Sharif","year":"2002","unstructured":"Sharif N, Kelly C, Crider J. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. J Ocul Pharmacol and Ther. 2002;18:313\u201324.","journal-title":"J Ocul Pharmacol And Ther"},{"key":"1078_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jtos.2019.06.002","volume":"17","author":"J Bu","year":"2019","unstructured":"Bu J, Wu Y, Cai X, Jiang N, Jeyalatha MV, Yu J, et al. Hyperlipidemia induces meibomian gland dysfunction. Ocul Surf. 2019;17:777\u201386.","journal-title":"The Ocul Surf"},{"key":"1078_CR19","doi-asserted-by":"publisher","unstructured":"Osae EA, Bullock T, Chintapalati M, Brodesser S, Hanlon S, Redfern R, et al. Obese mice with dyslipidemia exhibit meibomian gland hypertrophy and alterations in meibum composition and aqueous tear production. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21228772.","DOI":"10.3390\/ijms21228772"},{"key":"1078_CR20","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1167\/iovs.18-24013","volume":"59","author":"Y Yang","year":"2018","unstructured":"Yang Y, Huang C, Lin X, Wu Y, Ouyang W, Tang L, et al. 0.005% preservative-free latanoprost induces dry eye-like ocular surface damage via promotion of inflammation in mice. Invest Ophthalmol Vis Sci. 2018;59:3375\u201384. https:\/\/doi.org\/10.1167\/iovs.18-24013.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1078_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jtos.2023.06.007","volume":"29","author":"J Bu","year":"2023","unstructured":"Bu J, Wu Y, Li K, Zhang M, Zhang R, Sun L, et al. Transitory alkali exposure on meibomian gland orifices induces meibomian gland dysfunction. Ocul Surf. 2023;29:406\u201315. https:\/\/doi.org\/10.1016\/j.jtos.2023.06.007.","journal-title":"Ocul Surf"},{"key":"1078_CR22","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.ymeth.2010.01.007","volume":"50","author":"J Schlesinger","year":"2010","unstructured":"Schlesinger J, T\u00f6njes M, Schueler M, Zhang Q, Dunkel I, Sperling SR. Evaluation of the LightCycler 1536 instrument for high-throughput quantitative real-time PCR. Methods. 2010;50:S19\u201322. https:\/\/doi.org\/10.1016\/j.ymeth.2010.01.007.","journal-title":"Methods"},{"key":"1078_CR23","first-page":"4936","volume":"13","author":"S Zhou","year":"2022","unstructured":"Zhou S, Jia B, Kong J, Zhang X, Lei L, Tao Z, et al. Drug-induced fall risk in older patients: a pharmacovigilance study of FDA adverse event reporting system database. Front Pharmacol. 2022;13:4936.","journal-title":"Front Pharmacol"},{"key":"1078_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jclinepi.2021.07.014","volume":"139","author":"C Khouri","year":"2021","unstructured":"Khouri C, Revol B, Lepelley M, Mouffak A, Bernardeau C, Salvo F, et al. A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases. J Clin Epidemiol. 2021;139:191\u201398.","journal-title":"J Clin Epidemiol"},{"key":"1078_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2165\/00002018-200730070-00011","volume":"30","author":"A Bate","year":"2007","unstructured":"Bate A. Bayesian confidence propagation neural network. Drug Saf. 2007;30:623\u201325.","journal-title":"Drug Saf"},{"key":"1078_CR26","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/pds.2247","volume":"21","author":"C Berlin","year":"2012","unstructured":"Berlin C, Blanch C, Lewis DJ, Maladorno DD, Michel C, Petrin M, et al. Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and multi-item gamma Poisson Shrinker. Pharmacoepidemiol Drug Saf. 2012;21:622\u201330.","journal-title":"Pharmacoepidemiol And Drug Saf"},{"key":"1078_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/tvst.13.9.17","volume":"13","author":"SN Wu","year":"2024","unstructured":"Wu SN, Chen XD, Zhang QH, Wang YQ, Yan D, Xu CS, et al. Drug-related keratitis: a real-world FDA adverse event reporting system database study. Transl Vis Sci Technol. 2024;13:17. https:\/\/doi.org\/10.1167\/tvst.13.9.17.","journal-title":"Transl Vis Sci Technol"},{"key":"1078_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14454","author":"SN Wu","year":"2024","unstructured":"Wu SN, Chen XD, Yan D, Wang YQ, Wang SP, Guan WY, et al. Drug-associated glaucoma: a real-world study based on the food and Drug administration adverse event reporting system database. Clin Exp Ophthalmol. 2024. https:\/\/doi.org\/10.1111\/ceo.14454.","journal-title":"Clin Exp Ophthalmol"},{"key":"1078_CR29","doi-asserted-by":"publisher","first-page":"204209862412859","DOI":"10.1177\/20420986241285929","volume":"15","author":"SN Wu","year":"2024","unstructured":"Wu SN, Huang C, Wang YQ, Li X, Zhang SQ, Chen XD, et al. Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database. Ther Adv Drug Saf. 2024;15:20420986241285929. https:\/\/doi.org\/10.1177\/20420986241285929.","journal-title":"Ther Adv Drug Saf"},{"key":"1078_CR30","doi-asserted-by":"publisher","first-page":"100104","DOI":"10.1016\/j.apjo.2024.100104","volume":"13","author":"SN Wu","year":"2024","unstructured":"Wu SN, Huang C, Wang YQ, Chen XD, Li X, Zhang SQ, et al. Real-world large sample assessment of Drug-related dry eye risk: based on the FDA adverse event reporting system database. Asia Pac J Ophthalmol (phila). 2024;13:100104. https:\/\/doi.org\/10.1016\/j.apjo.2024.100104.","journal-title":"Asia Pac J Ophthalmol (phila)"},{"key":"1078_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2024.2446430","author":"X Li","year":"2025","unstructured":"Li X, Wu SN, Zhang SQ, Zhang ZJ, Wang MY, Chen CT, et al. Real-world analysis of medications inducing meibomian gland dysfunction: based on the FDA adverse event reporting system database. Expert Opin Drug Saf. 2025. https:\/\/doi.org\/10.1080\/14740338.2024.2446430.","journal-title":"Expert Opin Drug Saf"},{"key":"1078_CR32","doi-asserted-by":"publisher","first-page":"204209862413034","DOI":"10.1177\/20420986241303428","volume":"15","author":"R Liu","year":"2024","unstructured":"Liu R, Chen Y, Wu SN, Ma W, Qiu Z, Wang J, et al. Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database. Ther Adv Drug Saf. 2024;15:20420986241303428. https:\/\/doi.org\/10.1177\/20420986241303428.","journal-title":"Ther Adv Drug Saf"},{"key":"1078_CR33","doi-asserted-by":"publisher","first-page":"177820","DOI":"10.1016\/j.ejphar.2025.177820","volume":"1002","author":"SN Wu","year":"2025","unstructured":"Wu SN, Chen XD, Liu QT, Chen L, Sun L, Guan WY, et al. Drug-related visual blurring: findings from the U.S. Food and Drug administration adverse event reporting system database. Eur J Pharmacol. 2025;1002:177820. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177820.","journal-title":"Eur J Pharmacol"},{"key":"1078_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000003603","author":"SN Wu","year":"2025","unstructured":"Wu SN, Huang C, Chen XD, Liu QT, Chen L, Wang SP, et al. Retrospective cohort study of ocular adverse reactions to systemic drugs: insights from a multi-country spontaneous reporting database. Int J Surg. 2025. https:\/\/doi.org\/10.1097\/js9.0000000000003603.","journal-title":"Int J Surg"},{"key":"1078_CR35","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1038\/s41433-025-04035-2","volume":"39","author":"XD Chen","year":"2025","unstructured":"Chen XD, Xiao KH, Wu SN, Wei MY, Yu CF, Feng K, et al. Drug-related retinal detachment pharmacovigilance signals in the real world: evidence from the FDA adverse event reporting System. Eye (Lond). 2025;39:3284\u201393. https:\/\/doi.org\/10.1038\/s41433-025-04035-2.","journal-title":"Eye (Lond)"},{"key":"1078_CR36","doi-asserted-by":"publisher","first-page":"204209862513719","DOI":"10.1177\/20420986251371983","volume":"16","author":"K Xiao","year":"2025","unstructured":"Xiao K, Chen X, Wu S, Zhang Y, Chen R, Wu H, et al. Real-world large sample evaluation of drug-related blepharoptosis: a pharmacovigilance analysis of the FDA adverse event reporting System database. Ther Adv Drug Saf. 2025;16:20420986251371983. https:\/\/doi.org\/10.1177\/20420986251371983.","journal-title":"Ther Adv Drug Saf"},{"key":"1078_CR37","doi-asserted-by":"publisher","first-page":"40579","DOI":"10.1038\/s41598-025-24262-7","volume":"15","author":"Y He","year":"2025","unstructured":"He Y, Chen XD, Wu SN, Zhou CB, Wang PH, Tang SH, et al. Identifying high-risk drugs and demographic patterns in drug-induced liver injury from FAERS and CVARD analyses. Sci Rep. 2025;15:40579. https:\/\/doi.org\/10.1038\/s41598-025-24262-7.","journal-title":"Sci Rep"},{"key":"1078_CR38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1126\/science.277.5326.681","volume":"277","author":"Y Sugimoto","year":"1997","unstructured":"Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science. 1997;277:681\u201383.","journal-title":"Science"},{"key":"1078_CR39","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1038\/s41598-020-61775-9","volume":"10","author":"R Nakata","year":"2020","unstructured":"Nakata R, Nakamura Y, Hosomi S, Okuda H, Nishida Y, Sugita N, et al. Slco 2 a1 deficiency exacerbates experimental colitis via inflammasome activation in macrophages: a possible mechanism of chronic enteropathy associated with SLCO2A1 gene. Sci Rep. 2020;10:4883.","journal-title":"Sci Rep"},{"key":"1078_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.aanat.2018.12.003","volume":"222","author":"A Rath","year":"2019","unstructured":"Rath A, Eichhorn M, Tr\u00e4ger K, Paulsen F, Hampel U. In vitro effects of benzalkonium chloride and prostaglandins on human meibomian gland epithelial cells. Ann of Anat-Anatomischer Anz. 2019;222:129\u201338.","journal-title":"Ann of Anat-Anatomischer Anz"},{"key":"1078_CR41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4068\/cmj.2019.55.3.156","volume":"55","author":"JY Ha","year":"2019","unstructured":"Ha JY, Sung MS, Park SW. Effects of preservative on the meibomian gland in glaucoma patients treated with prostaglandin analogues. Chonnam Med J. 2019;55:156.","journal-title":"Chonnam Med J"},{"key":"1078_CR42","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.15252\/embj.201796685","volume":"36","author":"RZ Sabirov","year":"2017","unstructured":"Sabirov RZ, Merzlyak PG, Okada T, Islam MR, Uramoto H, Mori T, et al. The organic anion transporter SLCO 2A1 constitutes the core component of the maxi-cl channel. EMBO J. 2017;36:3309\u201324.","journal-title":"The EMBO J"},{"key":"1078_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1095\/biolreprod.106.053439","volume":"75","author":"DB Zaragoza","year":"2006","unstructured":"Zaragoza DB, Wilson RR, Mitchell BF, Olson DM. The interleukin 1beta-induced expression of human prostaglandin F2alpha receptor messenger RNA in human myometrial-derived ULTR cells requires the transcription factor, NFkappaB. Biol of Reproduction. 2006;75:697\u2013704.","journal-title":"Biol Of Reproduction"},{"key":"1078_CR44","doi-asserted-by":"publisher","first-page":"108176","DOI":"10.1016\/j.intimp.2021.108176","volume":"101","author":"C-C Sun","year":"2021","unstructured":"Sun C-C, Zhou Z-Q, Yang D, Chen Z-L, Zhou Y-Y, Wen W, et al. Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins. Int Immunopharmacol. 2021;101:108176.","journal-title":"Int Immunopharmacol"},{"key":"1078_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jtos.2014.12.002","volume":"13","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Teramukai S, Kinoshita S. Meibomian glands and ocular surface inflammation. Ocul Surf. 2015;13:133\u201349.","journal-title":"The Ocul Surf"},{"key":"1078_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.survophthal.2019.08.007","volume":"65","author":"S Sabeti","year":"2020","unstructured":"Sabeti S, Kheirkhah A, Yin J, Dana R. Management of meibomian gland dysfunction: a review. Survey of Ophthalmol. 2020;65:205\u201317.","journal-title":"Survey Of Ophthalmol"},{"key":"1078_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.63.1.30","volume":"63","author":"Y Guo","year":"2022","unstructured":"Guo Y, Zhang H, Zhao Z, Luo X, Zhang M, Bu J, et al. Hyperglycemia induces meibomian gland dysfunction. Invest Ophthalmol Visual Sci. 2022;63:30\u201330.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"1078_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.63.5.6","volume":"63","author":"R Liu","year":"2022","unstructured":"Liu R, Li J, Xu Y, Chen Z, Ye H, Tang J, et al. Melatonin attenuates lps-induced proinflammatory cytokine response and lipogenesis in human meibomian gland epithelial cells via MAPK\/NF-\u03baB pathway. Invest Ophthalmol Visual Sci. 2022;63:6\u20136.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"1078_CR49","first-page":"126","volume":"29","author":"HZ Mm","year":"2023","unstructured":"Mm HZ, Mm QW, Mm LY, Mm YG. Medication rules and mechanism of topical traditional Chinese medicine for meibomian gland dysfunction-related dry eye disease. Alter Ther in Health and Med. 2023;29:126\u201332.","journal-title":"Alternative Therapies In Health And Med"},{"key":"1078_CR50","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1167\/iovs.03-1145","volume":"45","author":"L Luo","year":"2004","unstructured":"Luo L, Li D-Q, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Visual Sci. 2004;45:4293\u2013301.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"1078_CR51","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/IJG.0000000000000140","volume":"24","author":"Y Liu","year":"2015","unstructured":"Liu Y, Liu Y, Xu D, Li J. Latanoprost-induced cytokine and chemokine release from human Tenon\u2019s capsule fibroblasts: role of MAPK and NF-\u03baB signaling pathways. J Glaucoma. 2015;24:635\u201341.","journal-title":"J Glaucoma"},{"key":"1078_CR52","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1167\/iovs.18-25571","volume":"59","author":"Y Qazi","year":"2018","unstructured":"Qazi Y, Kheirkhah A, Blackie C, Trinidad M, Williams C, Cruzat A, et al. Clinically relevant immune-cellular metrics of inflammation in meibomian gland dysfunction. Invest Ophthalmol Visual Sci. 2018;59:6111\u201323.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"1078_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jbt.10058","volume":"17","author":"A Maritim","year":"2003","unstructured":"Maritim A, Sanders A, Watkins Iii J. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17:24\u201338.","journal-title":"J Biochem Mol Toxicol"},{"key":"1078_CR54","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/antiox7100132","volume":"7","author":"JL Walters","year":"2018","unstructured":"Walters JL, De Iuliis GN, Nixon B, Bromfield EG. Oxidative stress in the male germline: a review of novel strategies to reduce 4-hydroxynonenal production. Antioxidants. 2018;7:132.","journal-title":"Antioxidants"},{"key":"1078_CR55","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/CIRCRESAHA.112.279760","volume":"112","author":"S Matsushima","year":"2013","unstructured":"Matsushima S, Kuroda J, Ago T, Zhai P, Park JY, Xie L-H, et al. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res. 2013;112:651\u201363.","journal-title":"Circ Res"},{"key":"1078_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.snb.2018.05.138","volume":"272","author":"M Govindasamy","year":"2018","unstructured":"Govindasamy M, Manavalan S, Chen S-M, Umamaheswari R, Chen T-W. Determination of oxidative stress biomarker 3-nitro-L-tyrosine using CdWO4 nanodots decorated reduced graphene oxide. Sensors and Actuators B: Chem. 2018;272:274\u201381.","journal-title":"Sensors And Actuators B: Chem"},{"key":"1078_CR57","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.cmet.2010.11.015","volume":"12","author":"X Qiu","year":"2010","unstructured":"Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010;12:662\u201367.","journal-title":"Cell Metab"},{"key":"1078_CR58","doi-asserted-by":"publisher","first-page":"DES163","DOI":"10.1167\/iovs.17-23402","volume":"59","author":"M Dogru","year":"2018","unstructured":"Dogru M, Kojima T, Simsek C, Tsubota K. Potential role of oxidative stress in ocular surface inflammation and dry eye disease. Invest Ophthalmol Visual Sci. 2018;59:DES163\u201368.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"1078_CR59","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.resp.2010.09.016","volume":"174","author":"S Pendyala","year":"2010","unstructured":"Pendyala S, Natarajan V. Redox regulation of nox proteins. Respir Physiol & Neurobiol. 2010;174:265\u201371.","journal-title":"Respir Physiol & Neurobiol"},{"key":"1078_CR60","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/pharmaceutics13091376","volume":"13","author":"A Dammak","year":"2021","unstructured":"Dammak A, Huete-Toral F, Carpena-Torres C, Martin-Gil A, Pastrana C, Carracedo G. From oxidative stress to inflammation in the posterior ocular diseases: diagnosis and treatment. Pharmaceutics. 2021;13:1376.","journal-title":"Pharmaceutics"},{"key":"1078_CR61","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/08958378.2011.576278","volume":"23","author":"M Ghanei","year":"2011","unstructured":"Ghanei M, Harandi AA. Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review. Inhalation Toxicol. 2011;23:363\u201371.","journal-title":"Inhalation Toxicol"},{"key":"1078_CR62","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/15321819.2020.1726774","volume":"41","author":"A Ahmad","year":"2020","unstructured":"Ahmad A, Ahsan H. Biomarkers of inflammation and oxidative stress in ophthalmic disorders. J Immunoassay and Immunochem. 2020;41:257\u201371.","journal-title":"J Immunoassay And Immunochem"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01078-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01078-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:57:16Z","timestamp":1771329436000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-025-01078-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01078-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6897699\/v1","asserted-by":"object"}]},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"36"}}